A Multicenter, Open-label, RebiSmart™ Autoinjector Ease of Use Study

NCT01036165 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

103

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DEVICE: RebiSmart™

Sponsor

EMD Serono